Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Guru Sonpavde, Joaquim Bellmunt, Jonathan E. Rosenberg, Dean F. Bajorin, Ashley Marie Regazzi, Toni K. Choueiri, Angela Q. Qu, Guenter Niegisch, Peter Albers, Andrea Necchi, Giuseppe di Lorenzo, Ronan Fougeray, Yu-Ning Wong, Srikala S. Sridhar, Yoo-Joung Ko, Matthew I. Milowsky, Matt D. Galsky, Gregory Russell Pond
Institutions: University of Alabama at Birmingham, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Memorial Sloan Kettering Cancer Center, Heinrich Heine University Düsseldorf, Fondazione IRCCS Istituto Nazionale dei Tumori, Federico II University Hospital, University of Naples Federico II, Pierre Fabre (France), Fox Chase Cancer Center, University Health Network, University of Toronto, Princess Margaret Cancer Centre, Sunnybrook Health Science Centre, Odette Cancer Centre, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, McMaster University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2482026024